Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: Takayasu arteritis is a rare large vessel vasculitis with incompletely understood etiology. This study was undertaken to perform the first unbiased genome-wide association analysis of Takayasu arteritis.

Methods: Two independent cohorts of patients with Takayasu arteritis from Turkey and North America were included in our study. The Turkish cohort consisted of 559 patients and 489 controls, and the North American cohort consisted of 134 patients and 1,047 controls of European ancestry. Genotyping was performed using the Omni1-Quad and Omni2.5 genotyping arrays. Genotyping data were subjected to rigorous quality control measures and subsequently analyzed to discover genetic susceptibility loci for Takayasu arteritis.

Results: We identified genetic susceptibility loci for Takayasu arteritis with a genome-wide level of significance in IL6 (rs2069837) (odds ratio [OR] 2.07, P = 6.70 × 10(-9)), RPS9/LILRB3 (rs11666543) (OR 1.65, P = 2.34 × 10(-8)), and an intergenic locus on chromosome 21q22 (rs2836878) (OR 1.79, P = 3.62 × 10(-10)). The genetic susceptibility locus in RPS9/LILRB3 lies within the leukocyte receptor complex gene cluster on chromosome 19q13.4, and the disease risk variant in this locus correlates with reduced expression of multiple genes including the inhibitory leukocyte immunoglobulin-like receptor gene LILRB3 (P = 2.29 × 10(-8)). In addition, we identified candidate susceptibility genes with suggestive levels of association (P < 1 × 10(-5)) with Takayasu arteritis, including PCSK5, LILRA3, PPM1G/NRBP1, and PTK2B.

Conclusion: Our findings indicate novel genetic susceptibility loci for Takayasu arteritis and uncover potentially important aspects of the pathophysiology of this form of vasculitis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414813PMC
http://dx.doi.org/10.1002/art.39035DOI Listing

Publication Analysis

Top Keywords

takayasu arteritis
24
susceptibility loci
16
genetic susceptibility
16
loci takayasu
12
intergenic locus
8
locus chromosome
8
chromosome 21q22
8
takayasu
8
arteritis genome-wide
8
genome-wide association
8

Similar Publications

Macaroni sign and takayasu arteritis: point-of-care ultrasound utility.

Rev Clin Esp (Barc)

September 2025

Servicio de Medicina Interna, Unidad de Ecografía Clínica, Hospital San Carlos, San Fernando, Cádiz, Spain. Electronic address:

View Article and Find Full Text PDF

Renal involvement in Takayasu arteritis (TA) has been reported, but glomerular lesions causing nephrotic syndrome (NS) are rare. This is a case report of TA presenting with NS due to secondary amyloidosis.A woman in her late 40s was diagnosed as TA at the age of 15 years presented with nephrotic range proteinuria.

View Article and Find Full Text PDF

Case Summary: A 20-year-old woman presented with acute coronary syndrome. Invasive coronary angiography revealed complete occlusion of the left main coronary artery. Subsequent computed tomography angiography demonstrated occlusion of the left subclavian, left vertebral, and superior mesenteric arteries, along with circumferential thickening of the abdominal aorta, consistent with Takayasu arteritis.

View Article and Find Full Text PDF

Background: Takayasu arteritis (TA) is a large-vessel vasculitis that primarily affects the aorta and the pulmonary and coronary arteries.

Case Summary: A 4-year-old boy was diagnosed in 2022 with pyoderma gangrenosum (PG) and required prolonged multidisciplinary care, including aggressive medical immunosuppression for severe skin lesions. In October 2024, after a period of clinical stability, he presented with a seizure and right-sided weakness.

View Article and Find Full Text PDF

The fragility of randomized controlled trials in large vessel vasculitis.

Autoimmun Rev

August 2025

Departments of Medicine and Health Research Methods, Evidence & Impact, McMaster University, Hamilton, Canada; Population Health Research Institute, Hamilton Health Sciences / McMaster University, Hamilton, Canada. Electronic address:

The fragility of randomized controlled trials (RCTs) of large vessel vasculitis (LVV) - defined as the minimum number of outcome events that would need to change to reverse the trial's conclusions - has not been comprehensively studied. We identified relevant RCTs with a systematic literature review till April 2025. The fragility index (FI)/ reverse fragility index (RFI) and fragility quotient (FQ, i.

View Article and Find Full Text PDF